台股 » 個股 » 奈米醫材 » 籌碼相關 » 券商分點績效

奈米醫材

(6612)
可現股當沖
  • 股價
    129.0
  • 漲跌
    ▼2.0
  • 漲幅
    -1.53%
  • 成交量
    81
  • 產業
    上櫃 生技醫療類股▲0.50%
  • 57人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
奈米醫材 (6612)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/19 ~ 2024/05/03     後一日»

券商獲利排行 - 2024/04/19 ~ 2024/05/03

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  5.96%1,602.5-911,693.5-11075186144.6145.5144.3129
  13.72%6800.7679.3-32133150.2149.5150.2129
  10.33%459.169.4389.6-23731143.3135.3145.2129
  12.85%435.315.7419.5-22123147.2132.3148.1129
  6.73%43518.1416.9-232144146.8146.3147.1129
  12.56%431.51.9429.6-21223149.4148.5149.5129
  1.83%404142.8261.2-20136156141.6141142.1129
  3.47%349-181.3530.3-502171141.6148.2139.6129
  4.01%309-17.6326.6-203353145.5145.9145.3129
  3.11%29317.6275.4-154964147.2147147.4129
  4.89%265-5.3270.3-201838142.6142.8142.5129
  3.77%255.69.3246.4-163147144.3144.1144.4129
  11.24%247.6-1.2248.8-14115146.8147.9146.8129
  11.74%24514.8230.2-11314149.1145149.9129
  10.47%201.719.1182.6-9413148.2144.5149.3129
  8.49%200.5-2.7203.2-11516147.6148147.5129
  13.28%197.50197.5-9010148.7145148.8129
  3.85%189.5161.428.1-23335140.7138.1143129
  12.28%177.831.6146.3-8210144.8131.5147.3129
  12.72%169.522.1147.4-729148139150.1129
  5.85%163.230.4132.8-61219147145.4148129
  7.20%152.739113.7-8715141.5137.6143.2129
  9.20%147.6-2.5150.1-8211145.9146.9145.7129
  8.12%1394396-6612142.6137.8145129
  10.50%1375780-459144.9137.6149129
  7.09%131.779.851.8-31013142.8138.3146.3129
  4.53%131.6-11.6143.1-91120145.3146144.9129
  3.05%131.3131.3003030143.7141.5145.8129
  12.67%1310131-707147.7145.5147.7129
  8.15%130.311119.3-6411145.3143.3146129
  0.34%126.5161.5-351257255146.8146.5147.1129
  10.71%1247.6116.4-718144.8138145.6129
  3.89%1200120-23023134.20134.2129
  2.94%115.516.599-141529135.7135136.1129
  0.29%111.532.778.8-5265270144.7144.6144.8129
  14.57%1100110-5051510151129
  8.54%109.643.166.5-459142.5137145.6129
  4.94%109.5-2.9112.4-6915147.9148.1147.7129
  10.78%109.10109.1-707144.6144.7144.6129
  8.34%109-2.2111.2-629145.1146144.9129
  10.38%107.5-3.5111-517147.9151147.5129
  14.29%107.50107.5-505150.50150.5129
  10.43%107.4-0.9108.4-617147.2148147.1129
  5.35%106.3-21.6127.9-11314141.9147.8140.6129
  10.18%104.510.693.9-527146.6142.5147.8129
  9.79%98098-7071430143129
  6.75%96-5.6101.6-8210142.2144.5141.7129
  0.96%92.5-93.5186-135467144.1145143.3129
  11.83%86.510.576-415146.3137.5148129
  7.16%83.562.620.9-178145.7140.9149.9129

券商虧損排行 - 2024/04/19 ~ 2024/05/03

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -10.82%-1,018.5-20.4-998.161653144.8145.1138.3129
  -4.88%-948-94800134134145148.6141.5129
  -12.23%-7190-719404001471470129
  -8.34%-690.81-691.849588142.9142.8143129
  -3.33%-429.1177-606.1418947144.7143.4147.2129
  -7.42%-365.4-46.4-319.1183415144.8145.8142.7129
  -12.24%-3600-36019200147.1147151129
  -1.91%-357-179.5-177.510128118146146.8145.2129
  -6.93%-331.521.9-353.432342140.7140151129
  -5.84%-323.4-9-314.4233915141.9142.1141.5129
  -6.85%-263.5-54.6-209132713142.5143.9139.7129
  -8.69%-23810.3-248.317192144.1143.6148.8129
  -11.30%-230.10-230.114140145.4145.40129
  -8.19%-2300-23020200140.5140.50129
  -12.02%-176.30-176.310100146.6146.6148.5129
  -3.10%-170-250.380.3-73138144.1148.5140.5129
  -2.83%-164.2-3.4-160.894030145145.1145129
  -2.56%-162.2-142-20.214342147.5149.2145.8129
  -2.26%-160.237.6-197.8124936144.7144.2145.3129
  -7.15%-151.8-17.5-134.39155141.5142.4138.9129
  -4.53%-135.517.9-153.411219142.4141.8143.8129
  -4.68%-132-140.28.3-11920140.9144.7137.3129
  -4.89%-127.510.5-1389189144.7144.3145.5129
  -8.21%-1187.6-125.58101143.7142.9150.5129
  -4.34%-116.9-45.3-71.751914142143.3140.1129
  -11.08%-111-71-40275143.1149134.8129
  -1.91%-106.5-122.315.8-13738146.4148.1144.8129
  -10.54%-106.50-106.5670144.4144.2147129
  -1.97%-10623.1-129.183729145.5145.1145.9129
  -6.55%-104-20.6-83.44116144.4145.7142.2129
  -3.58%-10114.8-115.8102010141.1140.6142.1129
  -2.68%-99.5-99.5002525148.3150.3146.3129
  -4.51%-972.2-99.27158143.3143.2143.4129
  -9.54%-96.6-55.9-40.7275144.7149.4138.2129
  -6.39%-96-45.3-50.75116136.5139.1131.6129
  -9.40%-95.5-95.50077145.2152138.4129
  -8.12%-92.5-42.4-50.1385142.4145.7137.2129
  -2.29%-92-109.717.7-12627148.8150.9146.7129
  -8.02%-91.93.8-95.7781143.1142.7146.5129
  -2.43%-90.1-11.1-79.142521148.5148.8148.2129
  -4.65%-86.7-24.6-62.23139143.4144.5141.8129
  -8.29%-846-90671144.8144150129
  -9.70%-83-8.8-74.2561142.6143.8135129
  -5.29%-82.9-11.6-71.34116142.6143.3141.3129
  -2.83%-82-108.326.2-21820145148.1142.1129
  -3.21%-79.5-61.1-18.411716145.5147.4143.6129
  -7.82%-797.6-86.6571144.4143.4151129
  -4.53%-77.814.6-92.56125143.1142.2145.1129
  -3.89%-77.534.6-112.110144142.1140.2148.9129
  -7.37%-77.55.1-82.6473150.2149.6151.3129
奈米醫材今年營收優於去年 預裝式人工水晶體明年Q4取證Anue鉅亨-2023/05/26
〈熱門股〉奈米醫材營運報捷 突破百元關卡創新高Anue鉅亨-2023/01/20
〈熱門股〉奈米醫材營運報捷 股價創一年半新高Anue鉅亨-2022/01/15
奈米醫材 相關文章
奈米醫材 相關影音